Chemical Communications 2013-02-18

A new class of NO-donor pro-drugs triggered by γ-glutamyl transpeptidase with potential for reno-selective vasodilatation.

Qingzhi Zhang, Agnieszka Kulczynska, David J Webb, Ian L Megson, Nigel P Botting

Index: Chem. Commun. (Camb.) 49(14) , 1389-91, (2013)

Full Text: HTML

Abstract

This communication describes the synthesis of a new class of N-hydroxyguanidine (NHG) pro-drugs which release nitric oxide (NO), triggered by the action of γ-glutamyl transpeptidase (γ-GT), and have potential for the treatment of acute renal injury/failure (ARI/ARF).

Related Compounds

Related Articles:

Inhibition of human γ-glutamyl transpeptidase: development of more potent, physiologically relevant, uncompetitive inhibitors.

2013-03-15

[Biochem. J. 450(3) , 547-57, (2013)]

Cardiohepatic interactions in heart failure: an overview and clinical implications.

2013-06-18

[J. Am. Coll. Cardiol. 61(24) , 2397-405, (2013)]

Pancreatic complications in pediatric choledochal cysts.

2013-09-01

[J. Pediatr. Surg. 48(9) , 1897-902, (2013)]

Low resolution X-ray structure of γ-glutamyltranspeptidase from Bacillus licheniformis: opened active site cleft and a cluster of acid residues potentially involved in the recognition of a metal ion.

2014-09-01

[Biochim. Biophys. Acta 1844(9) , 1523-9, (2014)]

The undernourished neonatal mouse metabolome reveals evidence of liver and biliary dysfunction, inflammation, and oxidative stress.

2014-03-01

[J. Nutr. 144(3) , 273-81, (2014)]

More Articles...